Noel Wallace Sells 126,304 Shares of Colgate-Palmolive (CL) Stock

Colgate-Palmolive (NYSE:CL) COO Noel Wallace sold 126,304 shares of the company’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the completion of the sale, the chief operating officer now owns 305,631 shares of the company’s stock, valued at approximately $22,549,455.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Colgate-Palmolive (NYSE:CL) opened at $69.76 on Monday. The firm has a market capitalization of $61,256.62, a P/E ratio of 30.60, a price-to-earnings-growth ratio of 2.58 and a beta of 0.75. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. Colgate-Palmolive has a 1-year low of $66.47 and a 1-year high of $77.91.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting the consensus estimate of $0.75. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.75 EPS. equities research analysts expect that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.29%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is presently 70.18%.

CL has been the subject of a number of analyst reports. BNP Paribas cut Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Morgan Stanley cut their target price on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research report on Tuesday, October 31st. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, October 17th. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Jefferies Group cut their target price on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a research report on Monday, October 30th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $77.71.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CL. Renaissance Technologies LLC lifted its stake in shares of Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after purchasing an additional 2,903,800 shares during the last quarter. APG Asset Management N.V. lifted its stake in shares of Colgate-Palmolive by 243.0% in the 3rd quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock valued at $296,557,000 after purchasing an additional 2,884,100 shares during the last quarter. Harding Loevner LP lifted its stake in shares of Colgate-Palmolive by 92.0% in the 3rd quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock valued at $176,329,000 after purchasing an additional 2,272,675 shares during the last quarter. First Eagle Investment Management LLC lifted its stake in shares of Colgate-Palmolive by 35.8% in the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after purchasing an additional 1,750,417 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after purchasing an additional 1,621,392 shares during the last quarter. Institutional investors and hedge funds own 72.85% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Noel Wallace Sells 126,304 Shares of Colgate-Palmolive (CL) Stock” was originally published by American Banking News and is owned by of American Banking News. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.americanbankingnews.com/2018/02/02/colgate-palmolive-cl-coo-sells-9318709-12-in-stock.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply